Today’s top gainers include the company Illumina Inc. (NASDAQ:ILMN) which is in the industry Biotechnology, gaining 2.89% today. In the last week its performance is 1.30%, and 29.08% for the past quarter. Currently, Illumina Inc., ILMN has a target price of 155.67, so today’s gain of 2.89% is a significant step towards its target price. The GAP today is therefore 0.50%.
Illumina Inc. (NASDAQ:ILMN), has a market cap of 26663.69, and is based in USA. Insider ownership is at 1.00%, and institutional ownership is 97.70%.
At the current price of 181.66, it has a dividend yield of *TBA, and its target price is 155.67. This is with a profit margin of 18.70%, and total debt/equity of 0.5. Illumina Inc. (NASDAQ:ILMN) has a P/E of 62.45, as well as a forward P/E of 44.47.
With a current EPS of 2.91, and a forecasted EPS growth for next year at 15.72%,Illumina Inc. (NASDAQ:ILMN) has had a EPS growth for the past five years at 28.90%. For the next five years EPS growth is projected to be 15.97%.
Performance for the year is 15.55%. Since its IPO date on 7/28/2000, the total performance to date is -5.36%.
Volume today for Illumina Inc. (NASDAQ:ILMN), is 1277600, while its average volume is 1049.55. Whilst the total gain today was 2.89%, it did have a day high of -0.55%.
Volatility for this week has been at 2.10%, and 2.20% for the month. The 52-week low for Illumina Inc., ILMN has been 42.93%, while the 52-week-high has reached -7.54%.
Looking at its return of investments, which is 16.60%, and its return on assets is 11.40%. Illumina Inc. (NASDAQ:ILMN) has an operating margin of 24.60%. With a sales growth of 11.30% quarter over quarter. Bearing in mind that Illumina Inc., ILMN is in the sector Healthcare, its long-term debt/equity is 0.5, and has a current ratio of 3.7 and 3.1 for quick ratio.
So what is the value of Illumina Inc.? Well its PEG is 3.91, and the P/S is 11.52, along with a P/B of 12.97. Meanwhile it has a p/cash of 18.71.